We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
320 result(s) found, displaying 171 to 180
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 15 mg tablet bottle.
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MELATONIN MR-TEVA melatonin 2 mg modified release tablet blister pack.
-
Prescription medicine decision summaryTGA decision: Radicava (edaravone) is approved to treat adults with a diagnosis of amyotrophic lateral sclerosis.
-
Prescription medicine registrationActive ingredients: sugammadex sodium.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 18 mg modified release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 36 mg modified release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 54 mg modified release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 27 mg modified release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GLATIRAMER ACETATE-TEVA glatiramer acetate 40 mg/1 mL solution for injection prefilled syringe.